March 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
July 2025
The global next-generation cancer therapeutics market size was evaluated at USD 86.20 billion in 2024 and is predicted to hit around USD 175.20 billion by 2034, growing at a CAGR of 7.35%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
June 2025
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
March 2025
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.36 billion in 2024 and is expected to hit around USD 9.53 billion by 2034, growing at a CAGR of 5.92%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
January 2025
The global cancer therapeutics and biotherapeutics market size was valued at USD 194.15 billion in 2024 and is expected to hit around USD 440.59 billion by 2034, growing at a CAGR of 8.54%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.38 billion in 2025, with a CAGR of 5.17%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The global Duchenne muscular dystrophy therapeutics market size was evaluated at USD 6.80 billion in 2025 and is predicted to hit around USD 26.88 billion by 2035, growing at a CAGR of 14.80%.
June 2026
The global endometrial cancer market size is valued at USD 31.09 billion in 2025 and is projected to hit around USD 53.76 billion in 2035 with a CAGR of 5.63%.
June 2026
The global targeted therapeutics market size was estimated at USD 85.75 billion in 2025 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
June 2026
The global narcolepsy therapeutics market size is accounted at USD 4.12 billion in 2025 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
June 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
May 2026
The global melanoma therapeutics market size accounted for USD 7.39 billion in 2025 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
May 2026
The global microbiome therapeutics market size is evaluated at USD 250.06 million in 2025 and is predicted to hit around USD 4,120.15 million by 2035, with a CAGR of 32.34%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
May 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 34.80 billion in 2025 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
May 2026
The pancreatic cancer market size was estimated at USD 3.25 billion in 2025 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
May 2026
The cosmetic tubes market size was estimated at USD 3.05 billion in 2025 and is projected to surpass around USD 4.82 billion by 2035 with a CAGR of 4.68%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com